Stay updated on Recombinant vs Marketed Flu Vaccines in Children Clinical Trial

Sign up to get notified when there's something new on the Recombinant vs Marketed Flu Vaccines in Children Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Recombinant vs Marketed Flu Vaccines in Children Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The record presents details of a completed Phase 3 study comparing recombinant and inactivated quadrivalent influenza vaccines in children and adolescents aged 3–17, including its design, eligibility criteria, outcomes, and locations.
    Difference
    48%
    Check dated 2026-11-09T12:58:36.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The site revision label changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error instead of a study record.
    Difference
    0.2%
    Check dated 2026-11-02T12:30:13.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    A notice appears stating that NIH is transitioning to the term “Super Intelligence” in place of “Artificial Intelligence” and linking to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-26T12:34:30.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T13:23:02.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-12T14:12:00.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    A 403 Forbidden page is now displayed for the study record, blocking access to the content. The previous study content and navigation details have been removed, replaced by the error boilerplate.
    Difference
    18%
    Check dated 2026-09-21T21:00:02.000Z thumbnail image

Stay in the know with updates to Recombinant vs Marketed Flu Vaccines in Children Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Recombinant vs Marketed Flu Vaccines in Children Clinical Trial page.